Depending on the susceptibility of the microorganism and the
concentration of the antibiotic, clindamycin may act both
bacteriostatically and bactericidally.


Kedd Clindamycin 300 mg, capsules:
Hard gelatin capsules with white body and blue cap.

Kedd Clindamycin 600 mg, capsules:
Hard gelatin capsules with white body and white cap.

Indications for use

should be used with the following indications:
Kedd is indicated for treatment of infections in adults and children,
caused by clindamycin-susceptible microorganisms:
-Infections of the upper respiratory tract (pharyngitis, tonsillitis, otitis
-Infections of the lower respiratory tract (bronchitis, pneumonia,
empyema, pulmonary abscess).
-Infections of the skin and soft tissues (acne, furunculosis, impetigo,
cellulitis, infected wounds, abscesses). In erysipelas, panaritium
and other similar specific infections, caused by clindamycinsusceptible pathogens, the achievement of a therapeutic effect can be expected.
-Infections of the bones and joints (osteomyelitis and septic
-Gynaecological infections (endometritis, cellulitis, colpitis, tuboovarian abscesses, salpingitis, inflammatory diseases of pelvic
organs). The product is administered in combination with an
appropriate antibiotic that is active against gram-negative aerobes.
-In cervicitis, caused by Chlamydia trachomatis, monotherapy with
clindamycin has the required therapeutic efficacy.
-Abdominal infections (peritonitis, abscesses of the abdominal
cavity), in combination with antibiotics that are active against gramnegative aerobic microorganisms.
-Septicaemia and endocarditis.
In some cases of endocarditis, sufficient efficacy of clindamycin
can be expected when the product has a bactericidal effect against
the infection causative agent at the concentrations that are attained in the serum.
-Odontogenic infections (periodontal abscess and periodontitis).
-Encephalitis caused by Toxoplasma in patients with AIDS.
The combination of clindamycin and pyrimethamine demonstrates therapeutic efficacy in patients intolerant to conventional therapy.
-Pneumonia caused by Pneumosystis jiroveci in patients with AIDS.
For patients who do not tolerate or do not respond adequately to
conventional therapy, clindamycin can be administered in combination with primaquine.
-Scarlet fever.
The use of the product should be in line with the national and local
guidelines and recommendations for conducting antibacterial therapy.

Mode of administration

Kedd capsules are swallowed whole with plenty of water to avoid
possible oesophageal irritation.
Route of administration: Orally.